Research Summary
A conjugate vaccine is a type of vaccine that combines a weak antigen from a bacteria or virus with a carrier protein to enhance the body's immune response. The weak antigen is typically from a bacterial capsule or a virus's surface protein that is not effective in eliciting a strong immune response on its own. By linking the weak antigen to a carrier protein, the immune system recognizes it more effectively, resulting in a robust immune response and the production of antibodies. Conjugate vaccines are widely used to protect against bacterial infections, particularly those caused by bacteria with polysaccharide capsules, such as Haemophilus influenzae type b (Hib), Streptococcus pneumoniae, and Neisseria meningitidis. These vaccines have been instrumental in reducing the incidence of serious bacterial infections, especially in young children and vulnerable populations.
According to DIResearch's in-depth investigation and research, the global Conjugate Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Conjugate Vaccine include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic, Bharat Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Conjugate Vaccine. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Conjugate Vaccine market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Conjugate Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Conjugate Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Conjugate Vaccine Include:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Bharat Biotech
Conjugate Vaccine Product Segment Include:
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Conjugate Vaccine Product Application Include:
Children
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Conjugate Vaccine Industry PESTEL Analysis
Chapter 3: Global Conjugate Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Conjugate Vaccine Major Regional Market Size and Forecast Analysis
Chapter 5: Global Conjugate Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Conjugate Vaccine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Conjugate Vaccine Market Overview 1.1 Product Definition and Statistical Scope 1.2 Conjugate Vaccine Product by Type 1.2.1 Global Conjugate Vaccine Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Hib Vaccine 1.2.3 Meningococcal Vaccine 1.2.4 Pneumococcal Vaccine 1.2.5 Others 1.3 Conjugate Vaccine Product by Application 1.3.1 Global Conjugate Vaccine Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Children 1.3.3 Adult 1.4 Global Conjugate Vaccine Market Revenue Analysis (2019-2030) 1.5 Conjugate Vaccine Market Development Status and Trends 1.5.1 Conjugate Vaccine Industry Development Status Analysis 1.5.2 Conjugate Vaccine Industry Development Trends Analysis 2 Conjugate Vaccine Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Conjugate Vaccine Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Conjugate Vaccine Market Analysis by Regions 4.1 Conjugate Vaccine Overall Market: 2023 VS 2024 VS 2030 4.2 Global Conjugate Vaccine Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Conjugate Vaccine Revenue and Market Share by Region (2019-2024) 4.2.2 Global Conjugate Vaccine Revenue Forecast by Region (2025-2030) 5 Global Conjugate Vaccine Market Size by Type and Application 5.1 Global Conjugate Vaccine Market Size by Type 5.2 Global Conjugate Vaccine Market Size by Application 6 North America 6.1 North America Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Conjugate Vaccine Market Size by Type 6.4 North America Conjugate Vaccine Market Size by Application 6.5 North America Conjugate Vaccine Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Conjugate Vaccine Market Size by Type 7.4 Europe Conjugate Vaccine Market Size by Application 7.5 Europe Conjugate Vaccine Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Conjugate Vaccine Market Size by Type 8.4 China Conjugate Vaccine Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Conjugate Vaccine Market Size by Type 9.4 APAC (excl. China) Conjugate Vaccine Market Size by Application 9.5 APAC (excl. China) Conjugate Vaccine Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Conjugate Vaccine Market Size by Type 10.4 Latin America Conjugate Vaccine Market Size by Application 10.5 Latin America Conjugate Vaccine Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Conjugate Vaccine Market Size by Type 11.4 Middle East & Africa Conjugate Vaccine Market Size by Application 11.5 Middle East & Africa Conjugate Vaccine Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Conjugate Vaccine Market Revenue by Key Manufacturers (2020-2024) 12.2 Conjugate Vaccine Competitive Landscape Analysis and Market Dynamic 12.2.1 Conjugate Vaccine Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Pfizer 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Pfizer Conjugate Vaccine Product Portfolio 13.1.3 Pfizer Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 GSK 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 GSK Conjugate Vaccine Product Portfolio 13.2.3 GSK Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Sanofi 13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Sanofi Conjugate Vaccine Product Portfolio 13.3.3 Sanofi Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Merck 13.4.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Merck Conjugate Vaccine Product Portfolio 13.4.3 Merck Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Walvax Biotechnology 13.5.1 Walvax Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Walvax Biotechnology Conjugate Vaccine Product Portfolio 13.5.3 Walvax Biotechnology Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Royal (Wuxi) Bio-Pharmaceutical 13.6.1 Royal (Wuxi) Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio 13.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Zhifei Biologic 13.7.1 Zhifei Biologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Zhifei Biologic Conjugate Vaccine Product Portfolio 13.7.3 Zhifei Biologic Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Bharat Biotech 13.8.1 Bharat Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Bharat Biotech Conjugate Vaccine Product Portfolio 13.8.3 Bharat Biotech Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Conjugate Vaccine Industry Chain Analysis 14.2 Conjugate Vaccine Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Conjugate Vaccine Typical Downstream Customers 14.4 Conjugate Vaccine Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support